Biocon Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Biocon Biologics Secures U.S. Market Entry Date for Bosaya and Aukelso , Denosumab Biosimilars".
Biocon Limited has informed the Exchange regarding a press release dated October 01, 2025, titled "Biocon Biologics Secures U.S. Market Entry Date for Bosaya and Aukelso , Denosumab Biosimilars".